Literature DB >> 7954446

Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer.

J Trapman1, H F Sleddens, M M van der Weiden, W N Dinjens, J J Konig, F H Schroder, P W Faber, F T Bosman.   

Abstract

To search for specific chromosome 8 aberrations in human prostate cancer, DNA was isolated from 44 human prostate tumor samples. Twenty six tumor samples were obtained from locally progressive tumors by transurethral resection, 12 were from radical prostatectomy specimens, and 6 were from lymph node metastases. Tumor DNAs were screened for allelic losses using 16 highly polymorphic microsatellite loci (14 covering the p arm, 2 on the q arm). In general, the detected deletions were large. In 59% of the tumor DNAs, allelic loss of 3 or more 8p loci was observed. Loss of 8p loci occurred in between 36 and 69% of the informative cases; for the two 8q markers, the percentages of loss were 11 and 25%, respectively, indicating preferential loss of (part of) 8p. In one tumor, two separate 8p deletions were found. The percentage of loss of heterozygosity was considerably higher in transurethral resection (65%) and lymph node metastases (83%) than in radical prostatectomy specimens (33%), suggesting that 8p deletion is a relatively late step in tumor progression. The maximal overlapping deleted region in all tumor DNAs is between the distal locus D8S133 and the proximal locus D8S87, indicating the localization of a candidate tumor suppressor gene within this region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954446

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  Molecular profiling of clinical tissues specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prang; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

Review 2.  Molecular profiling of clinical tissue specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prange; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1.

Authors:  Chun-Xiao Yu; Tong Jin; Wei-Wen Chen; Peng-Ju Zhang; Wen-Wen Liu; Heng-Yun Guan; Ju Zhang; Qing-Wei Liu; An-Li Jiang
Journal:  Mol Biol Rep       Date:  2009-03-05       Impact factor: 2.316

4.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

5.  Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.

Authors:  C L Wu; N Thakker; W Neary; G Black; R Lye; R T Ramsden; A P Read; D G Evans
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

6.  A unique human gene that spans over 230 kb in the human chromosome 8p11-12 and codes multiple family proteins sharing RNA-binding motifs.

Authors:  A Shimamoto; S Kitao; K Ichikawa; N Suzuki; Y Yamabe; O Imamura; Y Tokutake; M Satoh; T Matsumoto; J Kuromitsu; H Kataoka; K Sugawara; M Sugawara; M Sugimoto; M Goto; Y Furuichi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Genetic mapping of farnesyltransferase alpha(Fnta) to mouse chromosome 8.

Authors:  J C Porter; A Messer
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

8.  Common genetic variants in NEFL influence gene expression and neuroblastoma risk.

Authors:  Mario Capasso; Sharon Diskin; Flora Cimmino; Giovanni Acierno; Francesca Totaro; Giuseppe Petrosino; Lucia Pezone; Maura Diamond; Lee McDaniel; Hakon Hakonarson; Achille Iolascon; Marcella Devoto; John M Maris
Journal:  Cancer Res       Date:  2014-10-13       Impact factor: 12.701

9.  Roles for Nkx3.1 in prostate development and cancer.

Authors:  R Bhatia-Gaur; A A Donjacour; P J Sciavolino; M Kim; N Desai; P Young; C R Norton; T Gridley; R D Cardiff; G R Cunha; C Abate-Shen; M M Shen
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

10.  Allelic imbalance of 8p indicates poor survival in gastric cancer.

Authors:  Amy J French; Gina Petroni; Stephen N Thibideau; Mark Smolkin; Eric Bissonette; Franco Roviello; Jeffrey C Harper; Benjamin R Koch; Sarah A Anderson; Scott J Hebbring; Steven M Powell
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.